Big Pharma vs Big Pharma in court battles over biosimilar drugs

An Amgen sign is seen at the company’s office in South San Francisco, California in this October 21, 2013 file photo. REUTERS/Robert Galbraith/Files The line dividing makers of brand-name drugs and copycat medicines is blurring as companies known for innovativ... More »